DeepPsy extracts depression-related biomarkers from EEG and ECG to help clinicians choose a treatment. The Swiss National Science Foundation is granting CHF 1.99 million to PRECISE MDD, a randomised trial of 500 patients evaluating DeepPsy's approach, led by an independent academic consortium.
- Announced on
- Round
- Grant
- Amount
- CHF 2 M
- Location
- canton of Zurich
- Sector
- Health & medtech
Investors
- Fonds national suisse (FNS) lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic